Franziska Boess

2.1k total citations
31 papers, 1.4k citations indexed

About

Franziska Boess is a scholar working on Molecular Biology, Pharmacology and Hepatology. According to data from OpenAlex, Franziska Boess has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Hepatology. Recurrent topics in Franziska Boess's work include Pharmacogenetics and Drug Metabolism (7 papers), Gene expression and cancer classification (6 papers) and Liver physiology and pathology (4 papers). Franziska Boess is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Gene expression and cancer classification (6 papers) and Liver physiology and pathology (4 papers). Franziska Boess collaborates with scholars based in Switzerland, Germany and United Kingdom. Franziska Boess's co-authors include Laura Suter‐Dick, Adrian Roth, Urs A. Boelsterli, Thomas P. Singer, Thomas Weiser, Silvio Albertini, Rodolfo Gasser, Brian A. Naughton, Radina Kostadinova and Dawn Applegate and has published in prestigious journals such as PLoS ONE, Hepatology and The FASEB Journal.

In The Last Decade

Franziska Boess

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franziska Boess Switzerland 19 623 343 286 227 175 31 1.4k
Stéphane Dhalluin France 11 341 0.5× 233 0.7× 203 0.7× 195 0.9× 92 0.5× 19 919
Franck A. Atienzar Belgium 11 327 0.5× 243 0.7× 208 0.7× 204 0.9× 97 0.6× 12 913
Gerald J. Kolaja United States 10 397 0.6× 474 1.4× 181 0.6× 255 1.1× 152 0.9× 16 1.6k
Núria Jiménez Spain 24 661 1.1× 385 1.1× 292 1.0× 123 0.5× 159 0.9× 33 1.7k
Harry M. Olson United States 9 480 0.8× 452 1.3× 160 0.6× 268 1.2× 302 1.7× 16 2.0k
Stacey L. Dial United States 21 544 0.9× 198 0.6× 98 0.3× 86 0.4× 93 0.5× 27 1.3k
Sebastian Zellmer Germany 20 620 1.0× 108 0.3× 186 0.7× 106 0.5× 106 0.6× 55 1.4k
Jasminder Sahi United States 21 379 0.6× 539 1.6× 122 0.4× 78 0.3× 479 2.7× 44 1.3k
Dongmei Wang China 21 808 1.3× 178 0.5× 84 0.3× 60 0.3× 296 1.7× 63 1.7k

Countries citing papers authored by Franziska Boess

Since Specialization
Citations

This map shows the geographic impact of Franziska Boess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Boess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Boess more than expected).

Fields of papers citing papers by Franziska Boess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Boess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Boess. The network helps show where Franziska Boess may publish in the future.

Co-authorship network of co-authors of Franziska Boess

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Boess. A scholar is included among the top collaborators of Franziska Boess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Boess. Franziska Boess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sewing, Sabine, et al.. (2019). In Vitro Assessment of the Hepatotoxicity Potential of Therapeutic Oligonucleotides. Methods in molecular biology. 2036. 249–259. 4 indexed citations
2.
Boess, Franziska, Barbara Lenz, Juergen Funk, et al.. (2017). Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitro. Toxicology. 379. 48–61. 2 indexed citations
3.
Boess, Franziska, et al.. (2016). Biomarkers of Flutamide-Bioactivation and Oxidative Stress In Vitro and In Vivo. Drug Metabolism and Disposition. 44(4). 560–569. 6 indexed citations
4.
Sewing, Sabine, Franziska Boess, Annie Moisan, et al.. (2016). Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs. PLoS ONE. 11(7). e0159431–e0159431. 28 indexed citations
5.
Berger, Benjamin, Massimiliano Donzelli, Franziska Boess, et al.. (2016). Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail. Frontiers in Pharmacology. 7. 443–443. 68 indexed citations
6.
Zhang, Jitao David, Erich Küng, Franziska Boess, Ulrich Certa, & Martin Ebeling. (2015). Pathway reporter genes define molecular phenotypes of human cells. BMC Genomics. 16(1). 342–342. 19 indexed citations
7.
Kostadinova, Radina, Franziska Boess, Dawn Applegate, et al.. (2013). A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicology and Applied Pharmacology. 268(1). 1–16. 217 indexed citations
8.
Boess, Franziska, et al.. (2007). An in vitro study on 5-HT6 receptor antagonist induced hepatotoxicity based on biochemical assays and toxicogenomics. Toxicology in Vitro. 21(7). 1276–1286. 7 indexed citations
9.
Ruepp, Stefan, Franziska Boess, G Steiner, et al.. (2005). Assessment of hepatotoxic liabilities by transcript profiling. Toxicology and Applied Pharmacology. 207(2). 161–170. 28 indexed citations
10.
Beekman, Johanna M., et al.. (2005). Gene Expression Analysis of the Hepatotoxicant Methapyrilene in Primary Rat Hepatocytes: An Interlaboratory Study. Environmental Health Perspectives. 114(1). 92–99. 26 indexed citations
11.
Steiner, Guido, Laura Suter‐Dick, Franziska Boess, et al.. (2004). Discriminating Different Classes of Toxicants by Transcript Profiling. Environmental Health Perspectives. 112(12). 1236–1248. 101 indexed citations
12.
Boess, Franziska, et al.. (2004). In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. International Journal of Pharmaceutics. 279(1-2). 27–31. 14 indexed citations
13.
Huwyler, Jörg, et al.. (2004). In vitro investigation on the impact of the surface‐active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharmaceutics & Drug Disposition. 25(1). 37–49. 70 indexed citations
14.
15.
Boess, Franziska & Urs A. Boelsterli. (2002). Luminol as a Probe to Assess Reactive Oxygen Species Production from Redox-Cycling Drugs in Cultured Hepatocytes. Toxicology Mechanisms and Methods. 12(1). 79–94. 4 indexed citations
16.
Fountoulakis, Michael, Flavio Crameri, Franziska Boess, et al.. (2002). Modulation of Gene and Protein Expression by Carbon Tetrachloride in the Rat Liver. Toxicology and Applied Pharmacology. 183(1). 71–80. 46 indexed citations
17.
Boess, Franziska, Florence Ndikum-Moffor, Urs A. Boelsterli, & Stephen M. Roberts. (2000). Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochemical Pharmacology. 60(5). 615–623. 46 indexed citations
18.
Boess, Franziska, et al.. (1998). Antioxidant and Cytoprotective Properties ofd-Tagatose in Cultured Murine Hepatocytes. Toxicology and Applied Pharmacology. 148(1). 117–125. 34 indexed citations
19.
Boess, Franziska, et al.. (1998). Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-α gene knockout mice. Hepatology. 27(4). 1021–1029. 81 indexed citations
20.
Valeri, Fabio, et al.. (1997). Fructose and Tagatose Protect Against Oxidative Cell Injury by Iron Chelation. Free Radical Biology and Medicine. 22(1-2). 257–268. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Dhalluin Breakdown of academic impact, for papers by Franck A. Atienzar Breakdown of academic impact, for papers by Gerald J. Kolaja Breakdown of academic impact, for papers by Núria Jiménez Breakdown of academic impact, for papers by Harry M. Olson Breakdown of academic impact, for papers by Stacey L. Dial Breakdown of academic impact, for papers by Sebastian Zellmer Breakdown of academic impact, for papers by Jasminder Sahi Breakdown of academic impact, for papers by Dongmei Wang
Rankless by CCL
2026